메뉴 건너뛰기




Volumn , Issue 2, 2009, Pages

Interval debulking surgery for advanced epithelial ovarian cancer

Author keywords

Antineoplastic agents therapeutic use ; Chemotherapy, Adjuvant; Female; Humans; Ovarian neoplasms drug therapy; mortality; pathology; *surgery ; Randomized controlled trials as topic

Indexed keywords

BLEOMYCIN; CA 125 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

EID: 67650793590     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006014.pub4     Document Type: Review
Times cited : (34)

References (57)
  • 2
    • 55049129722 scopus 로고
    • A randomised trial of intervention debulking surgery and the duration of cis-platinum combination chmotherapy in advanced epithelial ovarian cancer (EOC)
    • Varma R, Blackledge G, Redman C, Luesley D, Chan KK, Mould J. A randomised trial of intervention debulking surgery and the duration of cis-platinum combination chmotherapy in advanced epithelial ovarian cancer (EOC). Annals of Oncology. 1990; Vol.1 (Suppl 9):4.
    • (1990) Annals of Oncology. , vol.1 , Issue.SUPPL. 9 , pp. 4
    • Varma, R.1    Blackledge, G.2    Redman, C.3    Luesley, D.4    Chan, K.K.5    Mould, J.6
  • 3
    • 0001120712 scopus 로고    scopus 로고
    • A phase III randomised study of interval secondary cytoreduction in patients with advanced stage ovarian carcinoma with suboptimal residual disease: A Gynecologic Oncology Group study
    • Rose PG, Nerenstone S, Brady M, Clarke Pearson D, Olt G, Rubin SC, et al.A phase III randomised study of interval secondary cytoreduction in patients with advanced stage ovarian carcinoma with suboptimal residual disease: a Gynecologic Oncology Group study. Proceedings of the American Society of Clinical Oncology. 2002; Vol.21 (Pt 1):201a.
    • (2002) Proceedings of the American Society of Clinical Oncology. , vol.21 , Issue.PART 1
    • Rose, P.G.1    Nerenstone, S.2    Brady, M.3    Clarke Pearson, D.4    Olt, G.5    Rubin, S.C.6
  • 6
    • 33645595957 scopus 로고    scopus 로고
    • After ten years follow-up interval debulking surgery remains a significant prognostic factoer for survival and progression free survival for advanced ovarian cancer: The EORTC Gynaecological Cancer Group study
    • van der Burg ME, Coens C, van Lent M, Kobierska A, Colombo N, Favalli G, et al.After ten years follow-up interval debulking surgery remains a significant prognostic factoer for survival and progression free survival for advanced ovarian cancer: the EORTC Gynaecological Cancer Group study. International Journal of Gynecological Cancer. 2004; Vol.14 (Suppl 1):3.
    • (2004) International Journal of Gynecological Cancer. , vol.14 , Issue.SUPPL. 1 , pp. 3
    • Van Der Burg, M.E.1    Coens, C.2    Van Lent, M.3    Kobierska, A.4    Colombo, N.5    Favalli, G.6
  • 8
    • 55049112893 scopus 로고
    • Intervention debulking surgery (IDS) does increase survival in advanced epithethelial ovarian cancer (OC) - An EORTC Gynecological Cancer Cooperative Group (GCCG) study
    • Van der Burg ME, Van Lent M, Kobierska A, Colombo N, Favalli G, Lacave AJ, et al.Intervention debulking surgery (IDS) does increase survival in advanced epithethelial ovarian cancer (OC) - an EORTC Gynecological Cancer Cooperative Group (GCCG) study. European Journal of Cancer. 1993; Vol.29 (Suppl 6):S132.
    • (1993) European Journal of Cancer. , vol.29 , Issue.SUPPL. 6
    • Van Der Burg, M.E.1    Van Lent, M.2    Kobierska, A.3    Colombo, N.4    Favalli, G.5    Lacave, A.J.6
  • 9
    • 55049085499 scopus 로고    scopus 로고
    • The survival benefit of interval debulking surgery (IDS) in advanced ovarian cancer is maintained during ten years; the EORTC GCG 55865 study
    • van der Burg MEL, Coens C, Van Lent M, Kobierska A, Colombo M, Favalli G, et al.The survival benefit of interval debulking surgery (IDS) in advanced ovarian cancer is maintained during ten years; the EORTC GCG 55865 study. International Journal of Gynecologic Cancer. 2005; Vol.15 (supplement 2):79.
    • (2005) International Journal of Gynecologic Cancer. , vol.15 , Issue.SUPPL. 2 , pp. 79
    • Van Der Burg, M.E.L.1    Coens, C.2    Van Lent, M.3    Kobierska, A.4    Colombo, M.5    Favalli, G.6
  • 10
    • 0028952438 scopus 로고
    • The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the EORTC
    • * van der Burg MEL, Van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al.The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the EORTC. The New England Journal of Medicine 1995;332(10):629-634
    • (1995) The New England Journal of Medicine , vol.332 , Issue.10 , pp. 629-634
    • Van Der Burg, M.E.L.1    Van Lent, M.2    Buyse, M.3    Kobierska, A.4    Colombo, N.5    Favalli, G.6
  • 11
  • 12
    • 55049139802 scopus 로고
    • Secondary tumor debulking itself does not increase survival in advanced epithelial ovarian cancer (EOC); an EORTC Gynecological Cancer Cooperative (GCCG) study
    • van der Burg MEL, van Lent M, Kobierska A, Colombo N, Favalli G, Lacave AJ, et al.Secondary tumor debulking itself does not increase survival in advanced epithelial ovarian cancer (EOC); an EORTC Gynecological Cancer Cooperative (GCCG) study. International Journal of Gynecological Cancer. 1993; Vol.3 (Suppl 1):52.
    • (1993) International Journal of Gynecological Cancer. , vol.3 , Issue.SUPPL. 1 , pp. 52
    • Van Der Burg, M.E.L.1    Van Lent, M.2    Kobierska, A.3    Colombo, N.4    Favalli, G.5    Lacave, A.J.6
  • 13
    • 0003164565 scopus 로고    scopus 로고
    • After 6 years follow-up intervention debulking surgery remains an independent prognostic factor for survival in advanced epithelial ovarian cancer: An EORTC Gynecological Cancer Cooperative Group study
    • van der Burg MEL, van Lent M, Kobierska A, Pitelli MR, Favalli G, Lacave AJ, et al.After 6 years follow-up intervention debulking surgery remains an independent prognostic factor for survival in advanced epithelial ovarian cancer: an EORTC Gynecological Cancer Cooperative Group study. International Journal of Gynecological Cancer. 1997; Vol.7 (Suppl 2):28.
    • (1997) International Journal of Gynecological Cancer. , vol.7 , Issue.SUPPL. 2 , pp. 28
    • Van Der Burg, M.E.L.1    Van Lent, M.2    Kobierska, A.3    Pitelli, M.R.4    Favalli, G.5    Lacave, A.J.6
  • 14
    • 32644489100 scopus 로고    scopus 로고
    • Diagnostic open laparoscopy in the management of advanced ovarian cancer
    • DOI 10.1016/j.ygyno.2005.09.060, PII S0090825805008504
    • Angioli R, Palaia I, Zullo MA, Muzii L, Manci N, Calcagno M, et al.Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecologic Oncology 2006;100:455-461 (Pubitemid 43246859)
    • (2006) Gynecologic Oncology , vol.100 , Issue.3 , pp. 455-461
    • Angioli, R.1    Palaia, I.2    Zullo, M.A.3    Muzii, L.4    Manci, N.5    Calcagno, M.6    Panici, P.B.7
  • 15
    • 0037227417 scopus 로고    scopus 로고
    • Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: A prospective longitudinal study
    • Chan YM, Ng TY, Ngan HY, Wong LC. Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study. Gynecologic Oncology 2003;88:9-16.
    • (2003) Gynecologic Oncology , vol.88 , pp. 9-16
    • Chan, Y.M.1    Ng, T.Y.2    Ngan, H.Y.3    Wong, L.C.4
  • 17
    • 0020015954 scopus 로고
    • Comparative study of 2 combined treatment regimens in stage-III to -IV ovarian cancer
    • Evdokimova NI, Grigorova TM. Comparative study of 2 combined treatment regimens in stage-III to -IV ovarian cancer. Voprosy onkologii 1982;28(7):28-34.
    • (1982) Voprosy Onkologii , vol.28 , Issue.7 , pp. 28-34
    • Evdokimova, N.I.1    Grigorova, T.M.2
  • 18
    • 33645340337 scopus 로고    scopus 로고
    • Gemcitabinecarboplatin- Paclitaxel combination as first-line therapy in advanced ovarian carcinoma: A single institution phase II study in 24 patients
    • Fuso L, Amant F, Neven P, Berteloot P, Vergote I. Gemcitabinecarboplatin- paclitaxel combination as first-line therapy in advanced ovarian carcinoma: A single institution phase II study in 24 patients. International Journal of Gynecological Cancer 2006;16 (Suppl 1):60-67.
    • (2006) International Journal of Gynecological Cancer , vol.16 , Issue.SUPPL. 1 , pp. 60-67
    • Fuso, L.1    Amant, F.2    Neven, P.3    Berteloot, P.4    Vergote, I.5
  • 20
    • 2442465879 scopus 로고    scopus 로고
    • Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer
    • DOI 10.1007/s10147-003-0377-x
    • Ikeba K, Okubo M, Takeda S, Kinoshita K, Maeda H. Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer. International Journal Clinical Oncology 2004;9:113-119 (Pubitemid 38619325)
    • (2004) International Journal of Clinical Oncology , vol.9 , Issue.2 , pp. 113-119
    • Ikeba, K.1    Okubo, M.2    Takeda, S.3    Kinoshita, K.4    Maeda, H.5
  • 21
    • 0035889879 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis
    • Kuhn W, Rutke S, Spathe K, Schmalfeldt B, Florack G, von Hundelshausen B, et al.Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis. Cancer 2001;92:2585-2591
    • (2001) Cancer , vol.92 , pp. 2585-2591
    • Kuhn, W.1    Rutke, S.2    Spathe, K.3    Schmalfeldt, B.4    Florack, G.5    Von Hundelshausen, B.6
  • 22
    • 70349162881 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy (CT) followed by debulking surgery vs upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma (EOC): A prospective, randomized study
    • Abstract 1957
    • Janga D, Kumar L, Kumar S, Shukla NK, Thulkar S, Singh R. Neoadjuvant chemotherapy (CT) followed by debulking surgery vs upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma (EOC): a prospective, randomized study. Proceedings of the American Society of Clinical Oncology 2003. 2007; Vol.22:487: Abstract 1957.
    • (2007) Proceedings of the American Society of Clinical Oncology 2003 , vol.22 , pp. 487
    • Janga, D.1    Kumar, L.2    Kumar, S.3    Shukla, N.K.4    Thulkar, S.5    Singh, R.6
  • 23
    • 70349155044 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by interval debulking surgery versus upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma: A prospective randomized study - Interim results
    • Abstract 5531
    • * Kumar L, Hariprasad R, Kumar S, Bhatla N, Thulkar S, Vijayaraghavan M, et al.Neoadjuvant chemotherapy followed by interval debulking surgery versus upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma: a prospective randomized study - interim results. Proceeding of the ASCO Annual Meeting 2007, Part I. 2007; Vol.28, issue 18 (Suppl):Abstract 5531.
    • (2007) Proceeding of the ASCO Annual Meeting 2007, Part I. , vol.28 , Issue.18 SUPPL.
    • Kumar, L.1    Hariprasad, R.2    Kumar, S.3    Bhatla, N.4    Thulkar, S.5    Vijayaraghavan, M.6
  • 24
    • 33645222471 scopus 로고    scopus 로고
    • Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery
    • Lee SJ, Kim BG, Lee JW, Park CS, Lee JH, Bae DS. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery. Journal of Obstetric and Gynaecological Research 2006;32:99-106.
    • (2006) Journal of Obstetric and Gynaecological Research , vol.32 , pp. 99-106
    • Lee, S.J.1    Kim, B.G.2    Lee, J.W.3    Park, C.S.4    Lee, J.H.5    Bae, D.S.6
  • 25
    • 8844266000 scopus 로고    scopus 로고
    • Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma
    • Liu EL, Mi RR. Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma. Chinese Medical Journal 2004;117:1547-1551
    • (2004) Chinese Medical Journal , vol.117 , pp. 1547-1551
    • Liu, E.L.1    Mi, R.R.2
  • 26
    • 70349133509 scopus 로고    scopus 로고
    • A randomized multicenter phase II study on neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian carcinomas (PRIMOVAR)
    • Abstract 15025
    • Park Simon T, Jänicke F, Ortmann O, Hilfrich J, Breitbach G, Höss C, et al.A randomized multicenter phase II study on neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian carcinomas (PRIMOVAR). Journal Clinical Oncology. 2006; Vol.Abstract 15025.
    • (2006) Journal Clinical Oncology
    • Park Simon, T.1    Jänicke, F.2    Ortmann, O.3    Hilfrich, J.4    Breitbach, G.5    Höss, C.6
  • 28
    • 0023878651 scopus 로고
    • The role of surgical reexploration following chemotherapy in ovarian cancer
    • Solomon J. The role of surgical reexploration following chemotherapy in ovarian cancer. Australian and New Zealand Journal of Obstetrics and Gynaecology 1988;28:121-126 (Pubitemid 18163544)
    • (1988) Australian and New Zealand Journal of Obstetrics and Gynaecology , vol.28 , Issue.2 , pp. 121-126
    • Solomon, J.1
  • 30
    • 0036498788 scopus 로고    scopus 로고
    • Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    • Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. Journal of Clinical Oncology 2002;20:1248-59.
    • (2002) Journal of Clinical Oncology , vol.20 , pp. 1248-1259
    • Bristow, R.E.1    Tomacruz, R.S.2    Armstrong, D.K.3    Trimble, E.L.4    Montz, F.J.5
  • 31
    • 33750905940 scopus 로고    scopus 로고
    • Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
    • Bristow RE, Chi DS. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecologic Oncology 2006;103(3):1070-6.
    • (2006) Gynecologic Oncology , vol.103 , Issue.3 , pp. 1070-1076
    • Bristow, R.E.1    Chi, D.S.2
  • 32
    • 33846367782 scopus 로고    scopus 로고
    • Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction
    • Bristow RE, Eisenhauer EL, Santillan A, Chi DS. Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecologic Oncology 2007;104(2):480-90.
    • (2007) Gynecologic Oncology , vol.104 , Issue.2 , pp. 480-490
    • Bristow, R.E.1    Eisenhauer, E.L.2    Santillan, A.3    Chi, D.S.4
  • 33
    • 0001910889 scopus 로고    scopus 로고
    • Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis
    • Egger M, Davey Smith G, Altman DG (eds). BMJ Publication Group, London
    • Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-Analysis in Context (2nd edition). BMJ Publication Group, London, 2001.
    • (2001) Systematic Reviews in Health Care: Meta-Analysis in Context (2nd Edition)
    • Deeks, J.J.1    Altman, D.G.2    Bradburn, M.J.3
  • 34
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple, graphical test
    • Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Smith, G.D.2    Schneider, M.3    Minder, C.4
  • 35
    • 57649159119 scopus 로고
    • The role of interval debulking surgery in advanced ovarian cancer: A meta-analysis
    • abstract
    • Elit A, Carey M. The role of interval debulking surgery in advanced ovarian cancer: a meta-analysis. International Journal of Gynecological Cancer. 1995; Vol. 5 (Suppl 1): 37 (abstract).
    • (1995) International Journal of Gynecological Cancer. , vol.5 , Issue.SUPPL. 1 , pp. 37
    • Elit, A.1    Carey, M.2
  • 36
    • 0347319568 scopus 로고    scopus 로고
    • Impact of interval debulking surgery on clinical outcome in primary unresectable FIGOstage IIIc ovarian cancer patients
    • Fanfani F, Ferrandina G, Corrado G, Fagotti A, Vito Zakut H, Mancuso S, et al.Impact of interval debulking surgery on clinical outcome in primary unresectable FIGOstage IIIc ovarian cancer patients. Oncology 2003;65:316-22.
    • (2003) Oncology , vol.65 , pp. 316-322
    • Fanfani, F.1    Ferrandina, G.2    Corrado, G.3    Fagotti, A.4    Vito Zakut, H.5    Mancuso, S.6
  • 37
    • 0016586897 scopus 로고
    • Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
    • Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Journal of the National Cancer Institute Monographs 1975;42:101-4.
    • (1975) Journal of the National Cancer Institute Monographs , vol.42 , pp. 101-104
    • Griffiths, C.T.1
  • 39
    • 85100415918 scopus 로고    scopus 로고
    • Cochrane Handbook for Systematic Reviews of Interventions 4.2.4
    • Higgins JPT, Green S, editors. [updated March 2005]. Chichester, UK: John Wiley & Sons, Ltd
    • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]. In: The Cochrane Library, Issue 2, 2005. Chichester, UK: John Wiley & Sons, Ltd, 2005.
    • (2005) The Cochrane Library, Issue 2, 2005
  • 40
    • 0028237380 scopus 로고
    • The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with sub-optimal residual epithelial ovarian carcinoma
    • Hoskins WJ, McGuire WP, Brady MF, Homsley HD, Creasman WT, Berman M, et al.The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with sub-optimal residual epithelial ovarian carcinoma. American Journal of Obstetetrics and Gynecology 1994;170:974-80.
    • (1994) American Journal of Obstetetrics and Gynecology , vol.170 , pp. 974-980
    • Hoskins, W.J.1    McGuire, W.P.2    Brady, M.F.3    Homsley, H.D.4    Creasman, W.T.5    Berman, M.6
  • 45
    • 0024496836 scopus 로고
    • Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer
    • Lawton FG, Redman CW, Luesley DM, Chan KK, Blackledge G. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer. Obstetrics and Gynecology 1989;73:61-5.
    • (1989) Obstetrics and Gynecology , vol.73 , pp. 61-65
    • Lawton, F.G.1    Redman, C.W.2    Luesley, D.M.3    Chan, K.K.4    Blackledge, G.5
  • 47
    • 0038162281 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
    • Mazzeo F, Berliere M, Kerger J, Squifflet J, Duck L, D'Hondt V, et al.Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecologic Oncology 2003;90:163-9.
    • (2003) Gynecologic Oncology , vol.90 , pp. 163-169
    • Mazzeo, F.1    Berliere, M.2    Kerger, J.3    Squifflet, J.4    Duck, L.5    D'Hondt, V.6
  • 49
    • 44449167562 scopus 로고    scopus 로고
    • Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    • Art. No.: CD005343. DOI: 10.1002/14651858.CD005343. [DOI: 10.1002/14651858; : ]
    • Morrison J, Swanton A, Collins S, Kehoe S. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database of Systematic Reviews 2007, Issue 4 Art. No.: CD005343. DOI: 10.1002/14651858.CD005343. [DOI: 10.1002/14651858; : ]
    • (2007) Cochrane Database of Systematic Reviews , Issue.4
    • Morrison, J.1    Swanton, A.2    Collins, S.3    Kehoe, S.4
  • 50
    • 0032583387 scopus 로고    scopus 로고
    • Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
    • Palmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-34.
    • (1998) Statistics in Medicine , vol.17 , pp. 2815-2834
    • Palmar, M.K.1    Torri, V.2    Stewart, L.3
  • 54
    • 1942462676 scopus 로고    scopus 로고
    • Gynecological Cancer Group of the EORTC. the role of interval debulking surgery in ovarian cancer
    • van der Burg ME, Vergote I, Gynecological Cancer Group of the EORTC. The role of interval debulking surgery in ovarian cancer. Current Oncology Reports 2003;5:473-81.
    • (2003) Current Oncology Reports , vol.5 , pp. 473-481
    • Van Der Burg, M.E.1    Vergote, I.2
  • 55
    • 55049085499 scopus 로고    scopus 로고
    • The survival benefit of interval debulking surgery (IDS) in advanced ovarian cancer is maintained during ten years; the EORTC GCG 55865 study
    • van der Burg MEL, Coens C, Van Lent M, Kobierska A, Colombo M, Favalli G, et al.The survival benefit of interval debulking surgery (IDS) in advanced ovarian cancer is maintained during ten years; the EORTC GCG 55865 study. International Journal of Gynecologic Cancer. 2005; Vol. 15 (supplement 2):79.
    • (2005) International Journal of Gynecologic Cancer. , vol.15 , Issue.SUPPL. 2 , pp. 79
    • Van Der Burg, M.E.L.1    Coens, C.2    Van Lent, M.3    Kobierska, A.4    Colombo, M.5    Favalli, G.6
  • 56
    • 0032422162 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
    • Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecologic Oncology 1998;71:431-6.
    • (1998) Gynecologic Oncology , vol.71 , pp. 431-436
    • Vergote, I.1    De Wever, I.2    Tjalma, W.3    Van Gramberen, M.4    Decloedt, J.5    Van Dam, P.6
  • 57
    • 24944574020 scopus 로고    scopus 로고
    • Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: A Gynecologic Oncology Group study
    • Wenzel L, Huang HQ, Monk BJ, Rose PG, Cella D. Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study. Journal Clinical Oncology 2005;23:5605-12.
    • (2005) Journal Clinical Oncology , vol.23 , pp. 5605-5612
    • Wenzel, L.1    Huang, H.Q.2    Monk, B.J.3    Rose, P.G.4    Cella, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.